Subscribe

What are you looking for?

Main Menu

明報新聞網

復星國際郭廣昌：持續加大投入生物醫藥

Future Wealths
Future Wealths
29 8 月, 2025
One Min Read
7 Views
0 Comments
復星國際（0656）董事長郭廣昌表示，未來將在生物醫藥領域持續加大投入，創新藥研發方面，已儲備一批未來在全球潛在市場規模50億至100億美元的管線產品。除了復宏漢霖（2696），還有復星凱瑞 CAR-T技術平台和成熟產品事業部的一些創新藥研發，都有成長空間。

原文: https://finance.mingpao.com/fin/instantf/20250829/1756466504075/%e5%be%a9%e6%98%9f%e5%9c%8b%e9%9a%9b%e9%83%ad%e5%bb%a3%e6%98%8c-%e6%8c%81%e7%ba%8c%e5%8a%a0%e5%a4%a7%e6%8a%95%e5%85%a5%e7%94%9f%e7%89%a9%e9%86%ab%e8%97%a5

Last Update: 29 8 月, 2025

Please share this article if you like it!

Link Copied!
Future Wealths
Written By

Future Wealths

Other Articles

Related Posts

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept